Bringing the fundamentals into focus…
Back to Zoetis Inc.
How Zoetis Inc. stacks up
ZTS · against 1,336 other Healthcare companies
Valuation
83/ 100
Near the top of its peers.
Ranked #222 of 1,337 · scores higher than 83% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 80–89, including ZTS · Click a bar to see the companies
Why valuation scores 83?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 79% of peers. EBITDA yield: 9.0% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 87% of peers. Free cash flow yield: 6.8% vs peer median 0.0%
- higher earnings for the price paid: stronger than 89% of peers. Earnings yield: 7.7% vs peer median 1.5%
Metric by metric
Position: dot = ZTS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ZTS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 7.4% | 1.5% | 89% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 9.7% | 4.2% | 79% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 6.8% | -1.0% | 87% | 20% | |
| Book yieldHigher is better · 1,306 reported | Not reported | 37.9% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around ZTSScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score